{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:24:05Z","timestamp":1792787045994,"version":"4.5.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Subprograma Atracci\u00f3 de Talent - Contractes Postdoctorals de la Universitat de Val\u00e8ncia","id":[{"id":"https:\/\/ror.org\/043nxc105","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/j.mayocp.2020.03.026","type":"journal-article","created":{"date-parts":[[2020,4,4]],"date-time":"2020-04-04T06:43:39Z","timestamp":1585982619000},"page":"1222-1230","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0424-4208","authenticated-orcid":false,"given":"Fabian","family":"Sanchis-Gomar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3906-1911","authenticated-orcid":false,"given":"Carl J.","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Perez-Quilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon M.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2020.03.026_bib1","author":"Shah"},{"key":"10.1016\/j.mayocp.2020.03.026_bib2","author":"Mahase"},{"key":"10.1016\/j.mayocp.2020.03.026_bib3","author":"Lippi"},{"key":"10.1016\/j.mayocp.2020.03.026_bib4","author":"World Health Organization"},{"key":"10.1016\/j.mayocp.2020.03.026_bib5","author":"Wu"},{"key":"10.1016\/j.mayocp.2020.03.026_bib6","author":"Emanuel"},{"key":"10.1016\/j.mayocp.2020.03.026_bib7","author":"Kuster"},{"key":"10.1016\/j.mayocp.2020.03.026_bib8","author":"Sparks"},{"issue":"7","key":"10.1016\/j.mayocp.2020.03.026_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00127-20","article-title":"Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus","volume":"94","author":"Wan","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.mayocp.2020.03.026_bib10","author":"Zou"},{"issue":"1","key":"10.1016\/j.mayocp.2020.03.026_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41368-020-0074-x","article-title":"High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa","volume":"12","author":"Xu","year":"2020","journal-title":"Int J Oral Sci"},{"key":"10.1016\/j.mayocp.2020.03.026_bib12","author":"Qi"},{"issue":"8","key":"10.1016\/j.mayocp.2020.03.026_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A\u00a0crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat Med"},{"issue":"6483","key":"10.1016\/j.mayocp.2020.03.026_bib14","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.mayocp.2020.03.026_bib15","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/MNH.0000000000000254","article-title":"Angiotensin converting enzyme 2 and diminazene: role in cardiovascular and blood pressure regulation","volume":"25","author":"Velkoska","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.mayocp.2020.03.026_bib16","doi-asserted-by":"crossref","first-page":"256294","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int J Pept"},{"issue":"5","key":"10.1016\/j.mayocp.2020.03.026_bib17","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A\u00a0novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ Res"},{"issue":"4","key":"10.1016\/j.mayocp.2020.03.026_bib18","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/01.HYP.0000090322.55782.30","article-title":"Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)","volume":"42","author":"Tallant","year":"2003","journal-title":"Hypertension"},{"issue":"14","key":"10.1016\/j.mayocp.2020.03.026_bib19","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.mayocp.2020.03.026_bib20","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus: a first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J\u00a0Pathol"},{"issue":"6","key":"10.1016\/j.mayocp.2020.03.026_bib21","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.tips.2004.04.001","article-title":"ACE2: from vasopeptidase to SARS virus receptor","volume":"25","author":"Turner","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.mayocp.2020.03.026_bib22","author":"Hoffmann"},{"key":"10.1016\/j.mayocp.2020.03.026_bib23","author":"Matsuyama"},{"key":"10.1016\/j.mayocp.2020.03.026_bib24","author":"Zheng"},{"key":"10.1016\/j.mayocp.2020.03.026_bib25","author":"Fang"},{"key":"10.1016\/j.mayocp.2020.03.026_bib26","doi-asserted-by":"crossref","first-page":"m810","DOI":"10.1136\/bmj.m810","article-title":"Preventing a covid-19 pandemic","volume":"368","author":"Watkins","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.mayocp.2020.03.026_bib27","author":"Esler"},{"key":"10.1016\/j.mayocp.2020.03.026_bib28","author":"Guan"},{"issue":"10229","key":"10.1016\/j.mayocp.2020.03.026_bib29","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"10223","key":"10.1016\/j.mayocp.2020.03.026_bib30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2020.03.026_bib31","author":"Wang"},{"key":"10.1016\/j.mayocp.2020.03.026_bib32","author":"Zhang"},{"key":"10.1016\/j.mayocp.2020.03.026_bib33","author":"Wu"},{"key":"10.1016\/j.mayocp.2020.03.026_bib35","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41421-020-0153-3","article-title":"Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2","volume":"6","author":"Zhou","year":"2020","journal-title":"Cell Discov"},{"issue":"2","key":"10.1016\/j.mayocp.2020.03.026_bib36","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/vim.2007.0108","article-title":"Identification of a novel transcriptional repressor (HEPIS) that interacts with nsp-10 of SARS coronavirus","volume":"21","author":"Hong","year":"2008","journal-title":"Viral Immunol"},{"issue":"6891","key":"10.1016\/j.mayocp.2020.03.026_bib37","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mayocp.2020.03.026_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1152\/physiolgenomics.00312.2005","article-title":"ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR","volume":"27","author":"Diez-Freire","year":"2006","journal-title":"Physiol Genomics"},{"issue":"3","key":"10.1016\/j.mayocp.2020.03.026_bib39","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1113\/expphysiol.2010.055277","article-title":"Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases","volume":"96","author":"Ferreira","year":"2011","journal-title":"Exp Physiol"},{"issue":"8","key":"10.1016\/j.mayocp.2020.03.026_bib40","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1042\/CS20110668","article-title":"Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes","volume":"123","author":"Tikellis","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.mayocp.2020.03.026_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.yjmcc.2013.11.017","article-title":"Angiotensin II induced proteolytic cleavage of myocardial ACE2 is mediated by TACE\/ADAM-17: a positive feedback mechanism in the RAS","volume":"66","author":"Patel","year":"2014","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"20","key":"10.1016\/j.mayocp.2020.03.026_bib42","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.mayocp.2020.03.026_bib43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"issue":"5","key":"10.1016\/j.mayocp.2020.03.026_bib44","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.mayocp.2020.03.026_bib45","doi-asserted-by":"crossref","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan","volume":"296","author":"Soler","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"issue":"8","key":"10.1016\/j.mayocp.2020.03.026_bib46","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1111\/jcmm.12573","article-title":"Perinatally administered losartan augments renal ACE2 expression but not cardiac or renal Mas receptor in spontaneously hypertensive rats","volume":"19","author":"Klimas","year":"2015","journal-title":"J\u00a0Cell Mol Med"},{"issue":"11","key":"10.1016\/j.mayocp.2020.03.026_bib47","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin Sci (Lond)"},{"issue":"4","key":"10.1016\/j.mayocp.2020.03.026_bib48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur Heart J"},{"issue":"8","key":"10.1016\/j.mayocp.2020.03.026_bib49","first-page":"1280","article-title":"Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling","volume":"19","author":"Walters","year":"2017","journal-title":"Europace"},{"issue":"6","key":"10.1016\/j.mayocp.2020.03.026_bib50","doi-asserted-by":"crossref","first-page":"e0198144","DOI":"10.1371\/journal.pone.0198144","article-title":"Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease","volume":"13","author":"Ramchand","year":"2018","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mayocp.2020.03.026_bib51","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1161\/HYPERTENSIONAHA.114.03743","article-title":"Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism","volume":"64","author":"Deshotels","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.mayocp.2020.03.026_bib52","author":"Gurwitz"},{"issue":"3","key":"10.1016\/j.mayocp.2020.03.026_bib53","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci China Life Sci"},{"issue":"1","key":"10.1016\/j.mayocp.2020.03.026_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.mayocp.2020.03.026_bib55","doi-asserted-by":"crossref","first-page":"e0213096","DOI":"10.1371\/journal.pone.0213096","article-title":"Circulating angiotensin peptides levels in acute respiratory distress syndrome correlate with clinical outcomes: a pilot study","volume":"14","author":"Reddy","year":"2019","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.mayocp.2020.03.026_bib56","doi-asserted-by":"crossref","first-page":"e14105","DOI":"10.14814\/phy2.14105","article-title":"Both aldosterone and spironolactone can modulate the intracellular ACE\/ANG II\/AT1 and ACE2\/ANG (1-7)\/MAS receptor axes in human mesangial cells","volume":"7","author":"Stoll","year":"2019","journal-title":"Physiol Rep"},{"issue":"19","key":"10.1016\/j.mayocp.2020.03.026_bib57","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.lfs.2005.09.038","article-title":"Age- and gender-related difference of ACE2 expression in rat lung","volume":"78","author":"Xie","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.mayocp.2020.03.026_bib58","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus","volume":"6","author":"Gu","year":"2016","journal-title":"Sci Rep"},{"issue":"13","key":"10.1016\/j.mayocp.2020.03.026_bib59","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1016\/j.jacc.2018.01.058","article-title":"Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use?","volume":"71","author":"Messerli","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620303153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619620303153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:32:44Z","timestamp":1758418364000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619620303153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":58,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0025619620303153"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.026","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2020.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}